Rapid, accurate test results generated at the point of care are key to improving the physician’s ability to quickly diagnose and initiate treatments that can improve clinical outcomes and save lives.

To address this need, Response Biomedical developed its Rapid Analyte Measurement Platform (RAMP). RAMP is a breakthrough in diagnostics that provides reliable information in minutes for both point-of-care testing and on-site laboratory use. However, the company’s RAMP 3.2 Reader could only conduct one test at a time and its 2-line/20-character monochrome display severely limited its functionality. To fully meet the needs of the emergency room and busy healthcare facilities, Response Biomedical needed a higher throughput instrument with a more sophisticated user interface and improved assay result handling capability.

Response Biomedical chose Stratos to design the new device.

Stratos leveraged its deep understanding of instrument architectures and proven point-of-care diagnostic device development ability to develop a new reader that would acquire and manage more patient results for clinicians, accept multiple assay types, be easy to use, and allow for configuration flexibility at the point of care. The project included more than 500 new product requirements and called for an exceptionally quick development cycle.

The Stratos team developed the RAMP 200 Reader: a multi-port, high-throughput reader that can process up to 36 tests per hour and features a touch-sensitive, color VGA display that includes a full-alphanumeric virtual keyboard. To provide real-time integration of patient data across multiple systems, Stratos software engineers designed the reader to be fully networkable and run on the healthcare industry-standard, HIPAA-compliant, POCT1A protocol. The instrument also features an automated Instrument Quality Control and a complex Liquid Quality Control test that verifies assays are running correctly, ensuring accurate results every time. The RAMP 200 is currently deployed in the U.S. through licensing arrangements for infectious disease diagnostics with 3M and cardiac panel diagnostics with Roche.